ReviewPharmaceuticals (Basel, Switzerland)2025

Repurposing Sigma-1 Receptor-Targeting Drugs for Therapeutic Advances in Neurodegenerative Disorders.

Kiarash Eskandari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.